Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.1.3.66 - phosphatidylinositol-3,4-bisphosphate 4-phosphatase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Adenocarcinoma
Inositol polyphosphate-4-phosphatase type II plays critical roles in the modulation of cadherin-mediated adhesion dynamics of pancreatic ductal adenocarcinomas.
Adenocarcinoma of Lung
Loss of tumor suppressor inositol polyphosphate 4-phosphatase type B impairs DNA double-strand break repair by destabilization of DNA tethering protein Rad50.
Asthma
A genetic variation in inositol polyphosphate 4 phosphatase a enhances susceptibility to asthma.
Resveratrol attenuates experimental allergic asthma in mice by restoring inositol polyphosphate 4 phosphatase (INPP4A).
Secretory Inositol Polyphosphate 4-Phosphatase Protects Against Airway Inflammation and Remodeling.
Ataxia
Elimination of INPP4A and SLC5A7 as candidate genes for congenital progressive ataxia and spastic paresis in pigs.
Breast Neoplasms
A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard.
An integrative analysis of PIK3CA mutation, PTEN, and INPP4B expression in terms of trastuzumab efficacy in HER2-positive breast cancer.
Basal biomarkers Nestin and INPP4b accurately identify intrinsic subtype in breast cancers that are weakly positive for estrogen receptor.
Basal biomarkers nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: Samples from the phase III SBG0102 clinical trial.
Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer.
Functional identification of a novel transcript variant of INPP4B in human colon and breast cancer cells.
Genetic interactions between INPP4B and RAD50 is prognostic of breast cancer survival.
Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.
INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
INPP4B and RAD50 have an interactive effect on survival after breast cancer.
INPP4B promotes PI3K?-dependent late endosome formation and Wnt/?-catenin signaling in breast cancer.
Investigating the duality of Inpp4b function in the cellular transformation of mouse fibroblasts.
miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer.
Phosphoinositide 3-kinase and INPP4B in human breast cancer.
Phosphoinositide phosphatases: just as important as the kinases.
Phosphoinositide signaling in cancer: INPP4B Akt(s) out.
PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ--Implications for Progression to Invasive Breast Carcinoma.
SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.
Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers.
Carcinogenesis
Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma.
In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.
Loss of tumor suppressor inositol polyphosphate 4-phosphatase type B impairs DNA double-strand break repair by destabilization of DNA tethering protein Rad50.
MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.
Regulation of PI(3)K/Akt signalling and cellular transformation by inositol polyphosphate 4-phosphatase-1.
SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.
The INPP4B paradox: Like PTEN, but different.
The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer.
Carcinoma
Alterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung.
Analysis of genes involved in the PI3K/Akt pathway in radiation- and MNU-induced rat mammary carcinomas.
Expression of inositol polyphosphate 4-phosphatase type II and the prognosis of oral squamous cell carcinoma.
INPP4B is highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survival.
INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway.
INPP4B suppresses prostate cancer cell invasion.
MicroRNA-4286 promotes esophageal carcinoma development by targeting INPP4A to evoke the JAK2/STAT3 pathway activation.
Upregulation of MicroRNA-935 Promotes the Malignant Behaviors of Pancreatic Carcinoma PANC-1 Cells via Targeting Inositol Polyphosphate 4-Phosphatase Type I Gene (INPP4A).
[Effects of long non-coding RNA FLJ37505 on the proliferation and migration of bladder cancer cells].
Carcinoma, Ductal
PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ--Implications for Progression to Invasive Breast Carcinoma.
Carcinoma, Hepatocellular
INPP4B inhibits cell proliferation, invasion and chemoresistance in human hepatocellular carcinoma.
Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.
Carcinoma, Intraductal, Noninfiltrating
PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ--Implications for Progression to Invasive Breast Carcinoma.
Carcinoma, Non-Small-Cell Lung
Overexpression of miR-4443 promotes the resistance of non-small cell lung cancer cells to epirubicin by targeting INPP4A and regulating the activation of JAK2/STAT3 pathway.
Carcinoma, Squamous Cell
Alterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung.
Colonic Neoplasms
Ese-3 contributes to colon cancer progression by downregulating EHD2 and transactivating INPP4B.
INPP4B is an oncogenic regulator in human colon cancer.
Investigating the duality of Inpp4b function in the cellular transformation of mouse fibroblasts.
Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
The INPP4B paradox: Like PTEN, but different.
Colorectal Neoplasms
Down-regulation of Inositol Polyphosphate 4-Phosphatase Type II Expression in Colorectal Carcinoma.
Inactivating Frameshift Mutation of INPP4B Encoding a PI3K Pathway Phosphatase in Gastric and Colorectal Cancers.
INPP4B exerts a dual function in the stemness of colorectal cancer stem-like cells through regulating Sox2 and Nanog expression.
INPP4B promotes colorectal cancer cell proliferation by activating mTORC1 signaling and cap-dependent translation.
MiR-1290 Contributes to Colorectal Cancer Cell Proliferation by Targeting INPP4B.
Drug Resistant Epilepsy
Inositol phosphatase INPP4A inhibits the apoptosis of in vitro neurons with characteristic of intractable epilepsy by reducing intracellular Ca2+ concentration.
Endometrial Neoplasms
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
Epilepsies, Myoclonic
Hindbrain malformation and myoclonic seizures associated with a deleterious mutation in the INPP4A gene.
Epilepsy
A new trick of INPP4A: Decreased expression of INPP4A in patients with temporal lobe epilepsy and pilocarpine-induced rat model.
Inositol phosphatase INPP4A inhibits the apoptosis of in vitro neurons with characteristic of intractable epilepsy by reducing intracellular Ca2+ concentration.
Epilepsy, Temporal Lobe
A new trick of INPP4A: Decreased expression of INPP4A in patients with temporal lobe epilepsy and pilocarpine-induced rat model.
Esophageal Achalasia
INPP4B overexpression and c-KIT downregulation in human achalasia.
Gallbladder Neoplasms
Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells.
Infections
Myeloid cell-specific inositol polyphosphate-4-phosphatase type I knockout mice impair bacteria clearance in a murine peritonitis model.
Insulin Resistance
INPP4B protects from metabolic syndrome and associated disorders.
Intellectual Disability
Whole exome sequencing identified a novel nonsense INPP4A mutation in a family with intellectual disability.
Laryngeal Neoplasms
Identification of inositol polyphosphate 4-phosphatase type II as a novel tumor resistance biomarker in human laryngeal cancer HEp-2 cells.
INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells.
Leukemia
High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome.
INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
INPP4B: the new kid on the PI3K block.
Phosphoinositide signaling in cancer: INPP4B Akt(s) out.
Leukemia, Myeloid, Acute
INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia.
Investigating the duality of Inpp4b function in the cellular transformation of mouse fibroblasts.
Lung Neoplasms
Loss of tumor suppressor inositol polyphosphate 4-phosphatase type B impairs DNA double-strand break repair by destabilization of DNA tethering protein Rad50.
miR-937 contributes to the lung cancer cell proliferation by targeting INPP4B.
Overexpression of miR-4443 promotes the resistance of non-small cell lung cancer cells to epirubicin by targeting INPP4A and regulating the activation of JAK2/STAT3 pathway.
Lymphoma
Kaposi Sarcoma in Association With an Extracavitary Primary Effusion Lymphoma Showing Unusual Intravascular Involvement: Report of a Case Harboring a FAM175A Germline Mutation.
Lymphoma, B-Cell
Biochemical and molecular aspects of aluminium chloride-induced neurotoxicity in mice and the protective role of Crocus sativus L. extraction and honey syrup.
Malaria
Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study.
Melanoma
A Tumor Suppressor Function for the Lipid Phosphatase INPP4B in Melanocytic Neoplasms.
INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.
Investigating the duality of Inpp4b function in the cellular transformation of mouse fibroblasts.
Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment.
MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma.
Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
The INPP4B paradox: Like PTEN, but different.
Microcephaly
Hindbrain malformation and myoclonic seizures associated with a deleterious mutation in the INPP4A gene.
Multiple Sclerosis
Genetic control of nerve conduction velocity may influence multiple sclerosis phenotype.
Muscle Spasticity
Elimination of INPP4A and SLC5A7 as candidate genes for congenital progressive ataxia and spastic paresis in pigs.
Nasopharyngeal Carcinoma
Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma.
Neoplasm Metastasis
In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.
INPP4B exerts a dual function in the stemness of colorectal cancer stem-like cells through regulating Sox2 and Nanog expression.
INPP4B inhibits cell proliferation, invasion and chemoresistance in human hepatocellular carcinoma.
INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.
INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway.
INPP4B suppresses prostate cancer cell invasion.
Neoplasms
A Tumor Suppressor Function for the Lipid Phosphatase INPP4B in Melanocytic Neoplasms.
Basal biomarkers Nestin and INPP4b accurately identify intrinsic subtype in breast cancers that are weakly positive for estrogen receptor.
Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer.
Breast Cancer Classification Based on Proteotypes Obtained by SWATH Mass Spectrometry.
Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.
Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities.
Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.
Down-regulation of Inositol Polyphosphate 4-Phosphatase Type II Expression in Colorectal Carcinoma.
Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma.
Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
Exome sequencing in 51 early onset non-familial CRC cases.
Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells.
Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breast.
Expression of inositol polyphosphate 4-phosphatase type II and the prognosis of oral squamous cell carcinoma.
Genetic interactions between INPP4B and RAD50 is prognostic of breast cancer survival.
Identification of inositol polyphosphate 4-phosphatase type II as a novel tumor resistance biomarker in human laryngeal cancer HEp-2 cells.
In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.
Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.
Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity.
Inositol polyphosphate phosphatases in human disease.
Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.
Inositol polyphosphate-4-phosphatase type II plays critical roles in the modulation of cadherin-mediated adhesion dynamics of pancreatic ductal adenocarcinomas.
INPP4B As A Prognostic And Diagnostic Marker Regulates Cell Growth Of Pancreatic Cancer Via Activating AKT.
INPP4B exerts a dual function in the stemness of colorectal cancer stem-like cells through regulating Sox2 and Nanog expression.
INPP4B inhibits cell proliferation, invasion and chemoresistance in human hepatocellular carcinoma.
INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.
INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency.
INPP4B is an oncogenic regulator in human colon cancer.
INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.
INPP4B overexpression enhances the antitumor efficacy of PARP inhibitor AG014699 in MDA-MB-231 triple-negative breast cancer cells.
INPP4B overexpression suppresses migration, invasion and angiogenesis of human prostate cancer cells.
INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
INPP4B promotes PI3K?-dependent late endosome formation and Wnt/?-catenin signaling in breast cancer.
INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway.
INPP4B reverses docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer.
INPP4B suppresses prostate cancer cell invasion.
INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells.
INPP4B: the new kid on the PI3K block.
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.
Investigating the duality of Inpp4b function in the cellular transformation of mouse fibroblasts.
Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment.
Loss of tumor suppressor inositol polyphosphate 4-phosphatase type B impairs DNA double-strand break repair by destabilization of DNA tethering protein Rad50.
MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma.
MicroRNA-940 Targets INPP4A or GSK3? and Activates the Wnt/?-Catenin Pathway to Regulate the Malignant Behavior of Bladder Cancer Cells.
miR-935 Inhibits Oral Squamous Cell Carcinoma and Targets Inositol Polyphosphate-4-phosphatase Type IA (INPP4A).
New functions of the inositol polyphosphate 5-phosphatases in cancer.
Novel nuclear translocation of inositol polyphosphate 4-phosphatase is associated with cell cycle, proliferation and survival.
Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.
Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers.
Phosphatases: the new brakes for cancer development?
Phosphatidylinositol 3,4-bisphosphate synthesis and turnover are spatially segregated in the endocytic pathway.
Phosphoinositide 3-kinase and INPP4B in human breast cancer.
Phosphoinositide phosphatases: just as important as the kinases.
Phosphoinositide signaling in cancer: INPP4B Akt(s) out.
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
Prognostic value of INPP4B protein immunohistochemistry in ovarian cancer.
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.
SHIP2 signaling in normal and pathological situations: Its impact on cell proliferation.
Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers.
The INPP4B paradox: Like PTEN, but different.
The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer.
Osteoporosis
Inositol polyphosphate 4-phosphatase B as a regulator of bone mass in mice and humans.
Inpp4b is a novel negative modulator of osteoclast differentiation and a prognostic locus for human osteoporosis.
Ovarian Neoplasms
Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities.
Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
INPP4B: the new kid on the PI3K block.
Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment.
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
Prognostic value of INPP4B protein immunohistochemistry in ovarian cancer.
Pancreatic Neoplasms
INPP4B As A Prognostic And Diagnostic Marker Regulates Cell Growth Of Pancreatic Cancer Via Activating AKT.
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
Upregulation of MicroRNA-935 Promotes the Malignant Behaviors of Pancreatic Carcinoma PANC-1 Cells via Targeting Inositol Polyphosphate 4-Phosphatase Type I Gene (INPP4A).
Paresis
Elimination of INPP4A and SLC5A7 as candidate genes for congenital progressive ataxia and spastic paresis in pigs.
phosphatidylinositol-3,4-bisphosphate 4-phosphatase deficiency
The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer.
Prostatic Neoplasms
A Tumor Suppressor Function for the Lipid Phosphatase INPP4B in Melanocytic Neoplasms.
Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.
Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-resistant prostate cancer cell line, PC3.
Estrogen receptor ? regulates AKT activity through up-regulation of INPP4B and inhibits migration of prostate cancer cell line PC-3.
Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity.
Inositol polyphosphate phosphatases in human disease.
INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.
INPP4B overexpression suppresses migration, invasion and angiogenesis of human prostate cancer cells.
INPP4B protects from metabolic syndrome and associated disorders.
INPP4B reverses docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer.
INPP4B suppresses prostate cancer cell invasion.
MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer.
Rhinitis, Allergic
MicroRNA-223-3p regulates allergic in?ammation by targeting INPP4A.
Sarcoma
Kaposi Sarcoma in Association With an Extracavitary Primary Effusion Lymphoma Showing Unusual Intravascular Involvement: Report of a Case Harboring a FAM175A Germline Mutation.
Seizures
A new trick of INPP4A: Decreased expression of INPP4A in patients with temporal lobe epilepsy and pilocarpine-induced rat model.
Hindbrain malformation and myoclonic seizures associated with a deleterious mutation in the INPP4A gene.
Squamous Cell Carcinoma of Head and Neck
Expression of inositol polyphosphate 4-phosphatase type II and the prognosis of oral squamous cell carcinoma.
Teratoma
Role of the inositol polyphosphate-4-phosphatase type II Inpp4b in the generation of ovarian teratomas.
Thyroid Neoplasms
In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.
INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.
Triple Negative Breast Neoplasms
Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.
INPP4B overexpression enhances the antitumor efficacy of PARP inhibitor AG014699 in MDA-MB-231 triple-negative breast cancer cells.
INPP4B promotes PI3K?-dependent late endosome formation and Wnt/?-catenin signaling in breast cancer.
The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer.
Urinary Bladder Neoplasms
Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo.
MicroRNA-940 Targets INPP4A or GSK3? and Activates the Wnt/?-Catenin Pathway to Regulate the Malignant Behavior of Bladder Cancer Cells.
Uterine Cervical Neoplasms
INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway.